Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Sell
4,357
-993
-19% -$197K 0.46% 65
2026
Q1
$787K Buy
5,350
+30
+0.6% +$4.39K 0.31% 104
2025
Q4
$647K Buy
5,320
+10
+0.2% +$1.17K 0.25% 124
2025
Q3
$573K Buy
5,310
+10
+0.2% +$933 0.22% 131
2025
Q2
$475K Buy
5,300
+10
+0.2% +$752 0.2% 148
2025
Q1
$360K Buy
5,290
+120
+2% +$8.64K 0.17% 166
2024
Q4
$326K Sell
5,170
-60
-1% -$4.05K 0.16% 175
2024
Q3
$405K Sell
5,230
-500
-9% -$39.2K 0.2% 141
2024
Q2
$472K Hold
5,730
0.27% 113
2024
Q1
$400K Sell
5,730
-400
-7% -$25.7K 0.23% 125
2023
Q4
$356K Buy
+6,130
New +$319K 0.22% 132

Other funds holding KLAC

Trueblood Wealth Management's KLAC Position: Q2 2026 in Review

Trueblood Wealth Management reduced its KLA (KLAC) stake by 19% in Q2 2026, selling an estimated $197K and leaving 4,357 shares worth $1.31M. The position accounts for 0.46% of the portfolio, ranked #65.

Trueblood Wealth Management first reported a position in KLAC in Q4 2023 and has held it in 11 quarters since. 2,473 funds tracked by Wall St. Rank hold KLAC as of Q2 2026.

  • Trueblood Wealth Management held 4,357 shares of KLA worth $1.31M as of Q2 2026.
  • Trueblood Wealth Management sold 993 KLA shares in Q2 2026, an estimated $197K.
  • KLA made up 0.46% of Trueblood Wealth Management's portfolio in Q2 2026, its #65 holding.
  • Trueblood Wealth Management first reported a position in KLA in Q4 2023 and has held it in 11 quarters since.
  • 2,473 funds tracked by Wall St. Rank held KLA as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.